A. Calmy, N. Ford, B. Hirschel, S. J. Reynolds, L. Lynen, E. Goemaere, F. G. de la Vega, L. Perrin and W. Rodriguez, “HIV Viral Load Monitoring in Resource-Limited Regions: Optional or Necessary?” Clinical Infectious Diseases, Vol. 44, No. 1, 2007, pp. 128-134. doi:10.1086/510073
 WHO, “Antiretroviral Therapy for HIV Infection in Adults and Adolescents, Recommendations for a Public Health Approach 2010 Revision,” 2010. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf
 NACO, “Antiretroviral Therapy Guidelines for HIV In-fected Adults and Adolescents Including Post Exposure Prophylaxis,” Ministry of Health and Family Welfare, 2007. http://www.nacoonline.org/upload/Policies%20&%20Guidelnes/1.%20Antiretroviral%20Therapy%20Guidelines% 20for%20HIVInfected%20Adults%20and%20Adolescents%20Including%20Post-exposure.pdf
 R. Kannangai, A. J. Kandathil, D. L. Ebenezer, G. Nithyanandam, P. Samuel, O. C. Abraham, T. D. Sudarsanam, S. A. Pulimood and G. Sridharan, “Evidence for Lower CD4+ T Cell and Higher Viral Load in Asymptomatic HIV-1 Infected Individuals of India: Implications for Therapy Initiation,” Indian Journal of Medical Microbiology, Vol. 26, No. 3, 2008, pp. 217-221. doi:10.4103/0255-0857.42031
 M. Irwin, “Low CD4+ T Lymphocyte Counts: A Variety of Causes and Their Implications to a Multifactorial Model of AIDS,” Virusmyth Homepage, 2001. “http://www.virusmyth.com/aids/hiv/milowcd4.htm
 K. Ray, S. M. Gupta, M. Bala, S. Muralidhar and J. Kumar, “CD4/CD8 Lymphocyte Counts in Healthy, HIV-Positive Individuals & AIDS Patients,” Indian Journal of Medical Research, Vol. 124, 2006, pp. 319-330.
 V. S. Attili, S. Sundar, V. P. Singh and M. Rai, “Validity of Existing CD4+ Classification in North Indians, in Predicting Immune Status,” Journal of Infection, Vol. 51, No.1, 2005, pp. 41-46. doi:10.1016/j.jinf.2004.08.022
 A. D. Kimmel, M. C. Weinstein, X. Anglaret, S. J. Goldie, E. Losina, Y. Yazdanpanah, E. Messou, K. L. Cotich, R. P. Walensky and K. A. Freedberg, “Monitoring of Antiretroviral Therapy in Resource-limited Settings: Discussion,” Journal of Acquired Immunodeficiency Syndrome, Vol. 54, No. 3, 2010, pp. 258-268. doi:10.1097/QAI.0b013e3181d0db97
 B. Boughton, “WHO-Mandated CD4 Monitoring for HIV Shows Poor Sensitivity, Specificity,” 17th Conference on Retroviruses and Opportunistic Infections (CROI), Abstract 111, San Francisco, 18 February 2010. http://www.medscape.com/viewarticle/717302
 M. B. Cauldbeck, C. O’Connor, M. B O’Connor, J. A. Saunders, B. Rao, V. G. Mallesh, N. Kotehalappa, P. Kumar, G. Mamtha, C. McGoldrick, R. B. S. Laing and K. S. Satish, “Adherence to Anti-Retroviral Therapy among HIV Patients in Bangalore, India,” AIDS Research and Therapy, Vol. 6, 2009, p. 7. doi:10.1186/1742-6405-6-7
 R. Murri, A. Ammassari, A. De Luca, A. Cingolani, P. Marconi, A. W. Wu and A. Antinori, “Self-Reported Non- adherence with Antiretroviral Drugs Predicts Persistent Condition,” HIV Clinical Trials, Vol. 2, No.4, 2001, pp. 323-329. doi:10.1310/KDM0-RU5W-NVTW-N9MC
 F. Forna, C. A. Liechty, P. Solberg, F. Asiimwe, W. Were, J. Mermin, P. Behumbiize, T. Tong, J. T. Brooks and P. J. Weidle, “Clinical Toxicity of Highly Active Antiretroviral Therapy in a Home-Based AIDS Care Program in Rural Uganda,” Journal of Acquired Immunodeficiency Syndrome, Vol. 44, No.4, 2007, pp. 456-462. doi:10.1097/QAI.0b013e318033ffa1
 R. Nuesch, P. Srasuebkul, J. Ananworanich, K. Ruxrungtham, P. Phanuphak and C. Duncombe, “Monitoring the Toxicity of Antiretroviral Therapy in Resource Limited Settings: A Prospective Clinical Trial Cohort in Thailand,” Journal of Antimicrobial Chemotherapy, Vol. 58, No. 3, 2006, pp. 637-644. doi:10.1093/jac/dkl313
 C. Adje, R. Cheingsong-Popov, T. Roels, G. Djomand, et al., “High Prevalence of Genotypic Antiretroviral (ART) Drug-Resistant HIV-1 Strains among HIV-1-Infected Patients Receiving ART in Abidjan, Ivory Coast,” Conference on Retroviruses and Opportunistic Infections, San Francisco, 30 January - 2 February 2000. http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102243620.html
 P. Scott, E. Arnold, B. Evans, A. Pozniak, G. Moyle, M. Shahmenesh, D. White, J. Shirley, P. Cane and D. Pillay, “Surveillance of HIV Antiretroviral Drug Resistance in Treated Individuals in England:1998-2000,” Journal of Antimicrobial Chemotherapy, Vol. 54, No. 3, 2003, pp. 469-473.
 J. W. Mellors, A. Munoz, J. V. Giorgi, J. B. Margolick, C. J. Tassoni, P. Gupta, L. A. Kingsley, J. A. Todd, A. J. S. R. Detels, J. P. Phair and C. R. Rinaldo Jr., “Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection,” Annals of Internal Medicine, Vol. 126, 1997, pp. 946-954.
 S. Napravnik, C. Poole, J. C. Thomas and J. J. Eron Jr., “Gender Difference in HIV RNA Levels: A Meta-Analysis of Published Studies,” Journal of Acquired Immunodeficiency Syndrome, Vol. 31, No. 1, 2002, pp. 11-19. doi:10.1097/01.QAI.0000026906.47530.AB
 S. B. Shade, C. Rappoport, D. LeSueur and M. C. Eberly, “Gender Differences in Viral Load: Results from Six Clinical Trials,” International Conference on AIDS, Durban, 9-14 July 2000. http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102238735.html